Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 2458220-05-6 Chemical Structure| 2458220-05-6

Structure of 2458220-05-6

Chemical Structure| 2458220-05-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 2458220-05-6 ]

CAS No. :2458220-05-6
Formula : C32H50ClN5O7S
M.W : 684.29
SMILES Code : O=C([C@H]1N(C([C@H](C(C)(C)C)NC(CCOCCOCCOCCN)=O)=O)C[C@H](O)C1)N[C@H](C2=CC=C(C3=C(C)N=CS3)C=C2)C.[H]Cl
English Name :(2S,4R)-1-((S)-1-Amino-14-(tert-butyl)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride
MDL No. :N/A

Safety of [ 2458220-05-6 ]

Application In Synthesis of [ 2458220-05-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 2458220-05-6 ]

[ 2458220-05-6 ] Synthesis Path-Downstream   1~11

  • 1
  • [ 2925306-36-9 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
With hydrogenchloride In 1,4-dioxane at 20℃; for 2h;
87.53 % With hydrogenchloride In 1,4-dioxane; dichloromethane at 0 - 20℃; 5.1 Step 1. (2S,4R)-1-((S)-1-amino-14-(tert-butyl)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride General procedure: (2S,4R)- 1 - ((S) - 1 -amino- 14-(tert-butyl)- 12-oxo-3,6,9-trioxa- 13-azapentadecan- 15- oyl)-4-hydroxy-N-((S)-l-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride was prepared from tert-butyl ((S)-14-((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4- methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15,15 -dimethyl- 12-oxo- 3.6.9-trioxa-13-azahexadecyl)carbamate (50 mg, 0.067 mmol) using Boc deprotection general procedure A (40 mg, 87.53% yield) as an Off-white sticky solid. LC-MS m/z 648.35 [M+H]+, Rt = 0.78 min.
87.53 % With hydrogenchloride In 1,4-dioxane; dichloromethane at 0 - 20℃; 5.1 Step 1. (2S,4R)-1-((S)-1-amino-14-(tert-butyl)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride General procedure: (2S,4R)- 1 - ((S) - 1 -amino- 14-(tert-butyl)- 12-oxo-3,6,9-trioxa- 13-azapentadecan- 15- oyl)-4-hydroxy-N-((S)-l-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride was prepared from tert-butyl ((S)-14-((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4- methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15,15 -dimethyl- 12-oxo- 3.6.9-trioxa-13-azahexadecyl)carbamate (50 mg, 0.067 mmol) using Boc deprotection general procedure A (40 mg, 87.53% yield) as an Off-white sticky solid. LC-MS m/z 648.35 [M+H]+, Rt = 0.78 min.
  • 2
  • [ 2458220-03-4 ]
  • [ 2458220-05-6 ]
  • [ CAS Unavailable ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 0 - 20℃; for 1h; Inert atmosphere;
  • 3
  • [ 2458220-03-4 ]
  • [ 2458220-05-6 ]
  • [ 2458219-60-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C / Inert atmosphere 2: trifluoroacetic acid / dichloromethane / 0 h / 0 - 20 °C
  • 4
  • [ 2349429-68-9 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 2: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 5
  • [ 27298-97-1 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 7 steps 1: sodium hydrogencarbonate / ethyl acetate; water / 2 h / 20 °C 2: palladium diacetate; potassium acetate / N,N-dimethyl acetamide / 12 h / 90 °C 3: hydrogenchloride / 1,4-dioxane; methanol / 4 h / 20 °C 4: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 0 - 20 °C / Inert atmosphere 5: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 6: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 7: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 6
  • [ 847728-89-6 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 6 steps 1: palladium diacetate; potassium acetate / N,N-dimethyl acetamide / 12 h / 90 °C 2: hydrogenchloride / 1,4-dioxane; methanol / 4 h / 20 °C 3: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 0 - 20 °C / Inert atmosphere 4: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 5: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 6: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 7
  • [ 1973408-97-7 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 5 steps 1: hydrogenchloride / 1,4-dioxane; methanol / 4 h / 20 °C 2: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 0 - 20 °C / Inert atmosphere 3: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 4: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 5: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 8
  • [ 1948273-00-4 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 0 - 20 °C / Inert atmosphere 2: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 3: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 4: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 9
  • [ 1997302-16-5 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 2: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 3: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 10
  • [ 630421-46-4 ]
  • [ 2458220-05-6 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 12 h / 0 - 20 °C / Inert atmosphere 2: dichloromethane / 4 h / 0 - 20 °C / Inert atmosphere 3: N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate; N-ethyl-N,N-diisopropylamine / N,N-dimethyl-formamide / 1 h / 0 - 20 °C 4: hydrogenchloride / 1,4-dioxane / 2 h / 20 °C
  • 11
  • [ 2458220-05-6 ]
  • [ 2919123-09-2 ]
  • [ 2925303-77-9 ]
YieldReaction ConditionsOperation in experiment
16 % Stage #1: 5-(benzo[b]thiophene-3-carboxamido)-6-(o-tolylamino)nicotinic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0℃; Stage #2: (2S,4R)-1-((S)-1-amino-14-(tert-butyl)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride In N,N-dimethyl-formamide at 20℃; 5.2 Step 2. 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine-1-carbonyl)-15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl)-6-(o-tolylamino)nicotinamide 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14-((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4- methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15,15 -dimethyl- 12-oxo- 3.6.9-trioxa-13-azahexadecyl)-6-(o-tolylamino)nicotinamide was prepared from (2S,4R)-1- ((S)- 1 -amino- 14-(tert-butyl)- 12-oxo-3,6,9-trioxa- 13-azapentadecan- 15-oyl)-4-hydroxy-N- ((S)- 1 -(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride (40 mg, 0.063 mmol) using acid amine coupling general procedure A and 5-(benzo[b]thiophene- 3-carboxamido)-6-(o-tolylamino)nicotinic acid (20 mg, 0.050 mmol). Purification with reversed-phase HPLC (Method J) provided 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14- ((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15, 15 -dimethyl- 12-oxo-3,6,9-trioxa- 13-azahexadecyl)-6-(o- tolylamino)nicotinamide (11 mg, 16% yield) as a white solid. LC-MS m/z 1034.30 [M+H]+, Rt = 1.50 min, HPLC: 91.35%, Rt = 6.13 min. 'HNMR(400 MHz, DMSO-D6) 5=10.04 (s, 1H), 8.98 (s, 1H), 8.70 (s, 1H), 8.51 - 8.35 (m, 4H), 8.21 (s, 1H), 8.13 (d, J = 2.1 Hz, 1H), 8.09 (dd, J = 1.2, 7.1 Hz, 1H), 7.85 (d, J = 9.4 Hz, 1H), 7.53 - 7.41 (m, 5H), 7.39 - 7.33 (m, 2H), 7.25 - 7.15 (m, 2H), 7.08 - 7.04 (m, 1H), 5.09 ( d, J = 2.9 Hz, 1H), 4.91 ( t, J = 7.2 Hz, 1H), 4.52 (d, J = 9.4 Hz, 1H), 4.42 (t, J = 8.0 Hz, 1H), 4.30 - 4.24 (m, 1H), 3.63 - 3.36 (m, 17H), 2.45 (s, 3H), 2.17 (s, 3H), 2.12 - 1.91 (m, 1H), 1.85 - 1.75 (m, 1H), 1.37 (d, J = 7.0 Hz, 3H), 0.92 (s, 9H) ppm
16 % Stage #1: 5-(benzo[b]thiophene-3-carboxamido)-6-(o-tolylamino)nicotinic acid With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 0℃; Stage #2: (2S,4R)-1-((S)-1-amino-14-(tert-butyl)-12-oxo-3,6,9-trioxa-13-azapentadecan-15-oyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride In N,N-dimethyl-formamide at 20℃; 5.2 Step 2. 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine-1-carbonyl)-15,15-dimethyl-12-oxo-3,6,9-trioxa-13-azahexadecyl)-6-(o-tolylamino)nicotinamide 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14-((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4- methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15,15 -dimethyl- 12-oxo- 3.6.9-trioxa-13-azahexadecyl)-6-(o-tolylamino)nicotinamide was prepared from (2S,4R)-1- ((S)- 1 -amino- 14-(tert-butyl)- 12-oxo-3,6,9-trioxa- 13-azapentadecan- 15-oyl)-4-hydroxy-N- ((S)- 1 -(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride (40 mg, 0.063 mmol) using acid amine coupling general procedure A and 5-(benzo[b]thiophene- 3-carboxamido)-6-(o-tolylamino)nicotinic acid (20 mg, 0.050 mmol). Purification with reversed-phase HPLC (Method J) provided 5-(benzo[b]thiophene-3-carboxamido)-N-((S)-14- ((2S,4R)-4-hydroxy-2-(((S)-l-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidine- 1 -carbonyl)- 15, 15 -dimethyl- 12-oxo-3,6,9-trioxa- 13-azahexadecyl)-6-(o- tolylamino)nicotinamide (11 mg, 16% yield) as a white solid. LC-MS m/z 1034.30 [M+H]+, Rt = 1.50 min, HPLC: 91.35%, Rt = 6.13 min. 'HNMR(400 MHz, DMSO-D6) 5=10.04 (s, 1H), 8.98 (s, 1H), 8.70 (s, 1H), 8.51 - 8.35 (m, 4H), 8.21 (s, 1H), 8.13 (d, J = 2.1 Hz, 1H), 8.09 (dd, J = 1.2, 7.1 Hz, 1H), 7.85 (d, J = 9.4 Hz, 1H), 7.53 - 7.41 (m, 5H), 7.39 - 7.33 (m, 2H), 7.25 - 7.15 (m, 2H), 7.08 - 7.04 (m, 1H), 5.09 ( d, J = 2.9 Hz, 1H), 4.91 ( t, J = 7.2 Hz, 1H), 4.52 (d, J = 9.4 Hz, 1H), 4.42 (t, J = 8.0 Hz, 1H), 4.30 - 4.24 (m, 1H), 3.63 - 3.36 (m, 17H), 2.45 (s, 3H), 2.17 (s, 3H), 2.12 - 1.91 (m, 1H), 1.85 - 1.75 (m, 1H), 1.37 (d, J = 7.0 Hz, 3H), 0.92 (s, 9H) ppm
 

Historical Records

Categories